跳至主要内容
临床试验/CTRI/2023/05/053036
CTRI/2023/05/053036已完成不适用

Organophosphorus poisoning:A retrospective study on clinical profiles and outcomes in ICU

Nadia Rose1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年1月6日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
To explore the epidemiological characteristics and clinical profile of patients admitted to ICU with OP

研究概览

简要总结

Organophosphorus compounds are widely used in India as insecticides and is the culprit in many

suicidal poisoning cases reported in the country.Acetylcholinesterase inhibition by

organophosphorus pesticides or organophosphate nerve agents can cause acute parasympathetic

system dysfunction, muscle weakness, seizures, coma, and respiratory failure. Prognosis

depends on the dose and relative toxicity of the specific compound, as well as pharmacokinetic

factors.

A literature search was conducted and the search revealed that only a few studies have

considered the clinical profile and outcomes of organophosphorus poisoning patients admitted

in the intensive care unit.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • All Patients with age more than or equal to 18 years admitted to ICU with history of acute organophosphorus poisoning.

排除标准

  • 1.Incomplete case records 2.Concurrent ingestion of another poisonous substance.

结局指标

主要结局

To explore the epidemiological characteristics and clinical profile of patients admitted to ICU with OP

时间窗: Admission to discharge or death

poisoning

时间窗: Admission to discharge or death

次要结局

  • To evaluate the outcomes including complications, inhospital mortality, and the predictors of(mortality)

研究者

发起方
Nadia Rose
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验